Visceral varicella zoster virus (VZV) after allogeneic hematopoietic stem cell transplant (HSCT) in pediatric patients with chronic graft-versus-host disease (cGVHD)

Journal of Pediatric Hematology/Oncology

Volumn 30, Issue 12, 2008, Pages 931-934

  Peritz, David C ^a,c   Duncan, Christine ^a   Kurek, Kyle ^b   Perez Atayde, Antonio R ^b   Lehmann, Leslie E ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c NONE   (United States)

Author keywords

Allogeneic; Chronic graft versus host disease; Hematopoietic stem cell transplant; Hyponatremia; Reactivation of varicella zoster virus

Indexed keywords

ACICLOVIR; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN; MEPREDNISONE; METHOTREXATE; PREDNISONE; RAPAMYCIN; STEROID; TACROLIMUS; ANTIVIRUS AGENT;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANAMNESIS; ARTICLE; CASE REPORT; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG MEGADOSE; FEMALE; GRAFT VERSUS HOST REACTION; HERPES ZOSTER; HUMAN; HUMAN TISSUE; LIVER BIOPSY; PRIORITY JOURNAL; VARICELLA ZOSTER VIRUS; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOTRANSPLANTATION; CHRONIC DISEASE; FATALITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; OPPORTUNISTIC INFECTION; PHYSIOLOGY; VIRUS ACTIVATION; VISCERA;

ACYCLOVIR; ANTIVIRAL AGENTS; CHRONIC DISEASE; FATAL OUTCOME; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; LEUKEMIA, MYELOID, ACUTE; OPPORTUNISTIC INFECTIONS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TRANSPLANTATION, HOMOLOGOUS; VIRUS ACTIVATION; VISCERA; YOUNG ADULT;

EID: 59149094220     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31817e4b14     Document Type: Article

References (18)

1. Thomson KJ, Hart DP, Banerjee L, et al. The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation. Bone Marrow Transplant. 2005;35:1065-1069.
2. Berman JN, Wang M, Berry W, et al. Herpes zoster infection in the post-hematopoietic stem cell transplant pediatric population may be preceded by transaminitis: an institutional experience. Bone Marrow Transplant. 2006;37:73-80.
3. Feldman S, Hughes WT, Daniel CB. Varicella in children with cancer: seventy-seven cases. Pediatrics. 1975;56:388-397.
4. Kawasaki H, Takayama J, Ohira M. Herpes zoster infection after bone marrow transplantation in children. J Pediatr. 1996;128: 353-356.
5. Leung TF, Chik KW, Li CK, et al. Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation. Bone Marrow Transplant. 2000;25:167-172.
6. David DS, Tegtmeier BR, O'Donnell MR, et al. Visceral varicella-zoster after bone marrow transplantation: report of a case series and review of the literature. Am J Gastroenterol. 1998;93: 810-813.
7. Bilgrami S, Chakraborty NG, Rodriguez-Pinero F, et al. Varicella zoster virus infection associated with high-dose chemotherapy and autologous stem-cell rescue. Bone Marrow Transplant. 1999; 23:469-474.
8. Koc Y, Miller KB, Schenkein DP, et al. Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome. Biol Blood Marrow Transplant. 2000;6:44-49.
9. Moffat JF, Stein MD, Kaneshima H, et al. Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice. J Virol. 1995;69:5236-5242.
10. Yagi T, Karasuno T, Hasegawa T, et al. Acute abdomen without cutaneous signs of varicella zoster virus infection as a late complication of allogeneic bone marrow transplantation: importance of empiric therapy with acyclovir. Bone Marrow Transplant. 2000;25:1003-1005.
11. Itoh M, Kawaguchi S, Yago K, et al. Acute abdominal pain preceding cutaneous manifestations of varicella zoster infection after allogeneic bone marrow transplantation. Tohoku J Exp Med. 2001; 195:61-63.
12. Stratman E. Visceral zoster as the presenting feature of disseminated herpes zoster. J Am Acad Dermatol. 2002;46:771-774.
13. Takatoku M, Muroi K, Kawano-Yamamoto C, et al. Involvement of the esophagus and stomach as a first manifestation of varicella zoster virus infection after allogeneic bone marrow transplantation. Intern Med. 2004;43:861-864.
14. Ingraham IE Jr, Estes NA, Bern MM, et al. Disseminated varicella-zoster virus infection with the syndrome of inappropriate anti-diuretic hormone. Arch Intern Med. 1983;143:1270-1271.
15. Maury S, Mary JY, Rabian C, et al. Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients. Br J Haematol. 2001;115: 630-641.
16. Nikkels AF, Delvenne P, Sadzot-Delvaux C, et al. Distribution of varicella zoster virus and herpes simplex virus in disseminated fatal infections. J Clin Pathol. 1996;49:243-248.
17. Rogers SY, Irving W, Harris A, et al. Visceral varicella zoster infection after bone marrow transplantation without skin involvement and the use of PCR for diagnosis. Bone Marrow Transplant. 1995; 15:805-807.
18. Erard V, Guthrie KA, Varley C, et al. One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation. Blood. 2007;110:3071-3077.